All >

News > Switzerland

Total search results: 2219 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Genedata AG. (11/6/12). "Press Release: Genedata Biologics for Streamlined Protein Engineering at PEGS Europe. UCB Pharma and Genedata Will Showcase Data Management and Workflow System". Vienna. 2012-11-06
Roche. (11/6/12). "Press Release: Roche Launches New LightCycler 96 System Enabling Broad Application of Its High-performance PCR Technology in Academic Research". Penzberg. 2012-11-06
Novartis AG. (11/5/12). "Press Release: Novartis Drug Votubia Approved in the EU as First Medication to Treat Patients with Non-cancerous Kidney Tumors Associated with TSC". Basel. 2012-11-05
Lonza Group Ltd.. (10/31/12). "Press Release: Lonza Delivers Solid Performance in Q3, Cost Improvement Programs on Track". Basel. 2012-10-31
Novartis AG. (10/31/12). "Press Release: Novartis to Start Construction of New Biotechnology Facility in Singapore with an Investment of Over USD 500 Million". Singapore. 2012-10-31
Tecan Group Ltd.. (10/30/12). "Press Release: Tecan and TAP Biosystems to Automate RAFT 3D Cell Culturing on the Freedom EVO. The RAFT System Will further Extend the 3D Cell Culturing Capabilities of the Freedom EVO Platform". Männedorf. 2012-10-30
Kymab Ltd.. (10/29/12). "Press Release: Kymab Strengthens Board of Directors with Appointments of Christian Itin, David Chiswell and Richard Davis". Cambridge. 2012-10-29
Novartis AG. (10/25/12). "Press Release: Recently Launched Products Support Novartis Sales in Third Quarter, Offsetting Patent Expiry, Pharmaceuticals Well-positioned with Further Pipeline Progress". Basel. 2012-10-25
Biotecon Diagnostics GmbH. (10/23/12). "Press Release: Biotecon Diagnostics Successfully Finishes a MicroVal Certification Again". Potsdam. 2012-10-23
Lonza Group Ltd.. (10/23/12). "Press Release: Lonza and OncoMed Pharmaceuticals Sign a Process Development and Manufacturing Collaboration and Multi-product GS License Agreement for Anti-cancer Therapeutics". Basel & Redwood City, CA. 2012-10-23
SGS S.A.. (10/22/12). "Press Release: SGS Acquires Sentinel Services (Proprietary) Ltd, South Africa". 2012-10-22
Actelion Ltd.. (10/22/12). "Press Release: Actelion Submits a New Drug Application to the FDA for Macitentan (Opsumit) for the Treatment of Patients with Pulmonary Arterial Hypertension". Allschwil. 2012-10-22
Analytik Jena AG. (10/19/12). "Press Release: New Combustion Module from Analytik Jena Offers Additional Applications for Ion Chromatography". 2012-10-19
Actelion Ltd.. (10/18/12). "Press Release: Actelion Announces Nine Months 2012 Financial Results. Total Product Sales of CHF 1,298.6 Million, Down 3% in Local Currencies". Allschwil. 2012-10-18
Covagen AG. (10/17/12). "Press Release: Covagen Enters into a Strategic Research Collaboration and License Agreement with Mitsubishi Tanabe for the Development of Bispecific FynomAbs". Zürich-Schlieren. 2012-10-17
Roche. (10/16/12). "Press Release: Roche Group Posts Strong Sales Growth in the Third Quarter". Basel. 2012-10-16
Addex Therapeutics S.A.. (10/12/12). "Press Release: Addex Therapeutics Raises $10 Million in a Private Placement to International Institutional Investors". Geneva. 2012-10-12
Cytos Biotechnology AG. (10/9/12). "Press Release: Cytos Biotechnology Ltd Appoints Dr. Christian Itin as Chief Executive Officer". Schlieren. 2012-10-09
Affimed Therapeutics AG. (10/8/12). "Press Release: Affimed Raises €15.5 Million in a Series D Financing Round". Heidelberg. 2012-10-08
4-Antibody AG. (10/8/12). "Press Release: 4-Antibody AG Receives Additional Milestone Payments from Human Genome Sciences". Basel. 2012-10-08
Evotec AG. (10/8/12). "Press Release: Evotec Receives Milestone in Drug Discovery Collaboration". Hamburg. 2012-10-08
Thermo Fisher Scientific Inc.. (10/3/12). "Press Release: Thermo Fisher Scientific and Mettler Toledo Introduce Integrated Titration/Ion Chromatography System Designed to Streamline Water Analysis Workflow". San José, CA. 2012-10-03
Merck Serono S.A.. (10/2/12). "Press Release: Merck Serono Announces the Creation of Asceneuron, the Third Spin-off Company from Its Entrepreneur Partnership Program. Asceneuron Will Develop Merck Serono’s Research Programs in the Area of Alzheimer’s Dis 2012-10-02
Roche. (10/2/12). "Press Release: Roche Expands Its Targeted Sequencing Portfolio with Launch of SeqCap EZ Oncology and Neurology Panels and New Exome Products". Madison, WI & Penzberg. 2012-10-02
Tecan Group Ltd.. (10/2/12). "Press Release: Tecan and JPT Peptide Technologies Announce Cooperation Agreement". Männedorf, Salzburg & Berlin. 2012-10-02
Roche. (10/1/12). "Press Release: Final Analysis of Phase III HERA Trial Confirmed One Year of Herceptin Treatment as Standard of Care in Early-stage HER2-positive Breast Cancer". Basel. 2012-10-01
Roche. (10/1/12). "Press Release: Roche’s Trastuzumab Emtansine (T-DM1) Significantly Extended Survival in People with Aggressive Form of Breast Cancer". Basel. 2012-10-01
Genedata AG. (9/25/12). "Press Release: Leco and Genedata Collaborate on Mass Spectrometry Data Analysis for High Resolution TOFMS Systems". St. Joseph, MI & Basel. 2012-09-25
Syngenta AG. (9/21/12). "Press Release: Syngenta Announces Public Offer for Devgen. Acquisition to Reinforce Leading Position in Global Rice Market". Basel. 2012-09-21
Genedata AG. (9/19/12). "Press Release: Genedata and Insilico Biotechnology Integrate Industrial Biotechnology Platforms". Munich. 2012-09-19
Genedata AG. (9/17/12). "Press Release: UCB Pharma Advances Next-generation Antibody Discovery with Genedata Biologics". Basel. 2012-09-17
Takeda Pharmaceutical Co. Ltd.. (9/12/12). "Press Release: Takeda Completes Its Russian Pharmaceutical Manufacturing Facility". Zürich. 2012-09-12
Genedata AG. (9/10/12). "Press Release: Genedata Expressionist MSX for Academics Released at HUPO 2912. Affordable, Ready-to-run MS Data Analysis System". Basel. 2012-09-10
Boehringer Ingelheim. (9/6/12). "Press Release: Boehringer Ingelheim and the ETH Zurich Announce Diabetes and Obesity Research Collaboration". Ingelheim. 2012-09-06
Merck Serono. (9/3/12). "Press Release: Merck Serono Announces the Creation of Quartz Bio, a Bioinformatics Company Formed through Its Entrepreneur Partnership Program". Geneva. 2012-09-03
Novartis AG. (8/30/12). "Press Release: Novartis QVA149 Phase III Study Meets Primary Endpoint in Reducing Exacerbations in COPD Patients, Filing in EU and Japan by End of Year". Basel. 2012-08-30
Evolva Holding S.A.. (8/29/12). "Press Release: Evolva Reports Interim Results for First Six Months of 2012". Reinach. 2012-08-29
AstraZeneca plc. (8/28/12). "Press Release: Pascal Soriot Appointed Chief Executive Officer of AstraZeneca". 2012-08-28
Roche. (8/28/12). "Press Release: Changes to the Roche Corporate Executive Committee. Daniel O’Day Appointed New Head of Roche Pharma – Roland Diggelmann Will Assume the Position Head of Roche Diagnostics". Basel. 2012-08-28
Dualsystems Biotech AG. (8/28/12). "Press Release: Announced Drug Profiling Agreement with e-Therapeutics plc". Schlieren. 2012-08-28
Roche. (8/27/12). "Press Release: New Data from Phase III EMILIA Study Showed Roche’s Trastuzumab Emtansine (T-DM1) Significantly Improved Survival of People with HER2-positive Metastatic Breast Cancer". Basel. 2012-08-27
Devgen NV. (8/27/12). "Press Release: Devgen Half Year Report 2012". Ghent. 2012-08-27
Ablynx N.V.. (8/22/12). "Press Release: Ablynx Announces Half-year 2012 Results". Ghent. 2012-08-22
Tecan Group Ltd.. (8/21/12). "Press Release: Tecan’s New QC Kit for Freedom EVO Workstations Released". Männedorf. 2012-08-21
Basilea Pharmaceutica Ltd.. (8/16/12). "Press Release: Basilea Reports Its Half-year Results". Basel. 2012-08-16
Tecan Group Ltd.. (8/16/12). "Press Release: Moderate Increase in Sales and Solid Profitability for Tecan in the First Half of 2012". Männedorf. 2012-08-16
Merck Serono S.A.. (8/9/12). "Press Release: Agreement Signed to Put an End to the Labor Dispute over the Merck Serono Sites in Geneva and the Vaud Canton". Geneva. 2012-08-09
EBD Group. (8/7/12). "Press Release: BIO-Europe 2012 to Be Held in Hamburg, Germany. »Gateway to the Nordic Region« Is Ripe for Dealmaking". Zurich & Hamburg. 2012-08-07
Novartis AG. (8/6/12). "Press Release: Novartis and University of Pennsylvania Form Broad-based R&D Alliance to Advance Novel T-cell Immunotherapies to Treat Cancer". Basel. 2012-08-06
Lonza Group Ltd.. (8/2/12). "Press Release: Lonza Announces License Agreement with iPS Academia Japan". Walkersville, MD. 2012-08-02
MorphoSys AG. (8/2/12). "Press Release: MorphoSys AG Reports Results for the First Six Months of 2012". 2012-08-02
Merck Serono. (7/30/12). "Press Release: Merck Serono Announces Creation of First Spin-off Company from Its Entrepreneur Partnership Program. Prexton Therapeutics Will Develop Merck Serono’s Glutamate Receptors Programs for Parkinson’s Disease". Geneva. 2012-07-30
Basilea Pharmaceutica Ltd.. (7/30/12). "Press Release: Basilea Submits European Marketing Authorization Application of Ceftobiprole for the Treatment of Pneumonia". Basel. 2012-07-30
Novartis AG. (7/30/12). "Press Release: Novartis Drug Afinitor Approved by European Commission to Treat Patients with the Most Common Form of Advanced Breast Cancer". Basel. 2012-07-30
Roche. (7/26/12). "Press Release: Roche Posts Strong Operating First-half Results, on Track to Meet 2012 Guidance". Basel. 2012-07-26
Lonza Group Ltd.. (7/25/12). "Press Release: Lonza Delivered Solid Business Performance in the First Half of 2012". Basel. 2012-07-25
Basilea Pharmaceutica Ltd.. (7/23/12). "Press Release: Basilea Announces Completion of Toctino (alitretinoin) Transaction with Stiefel. Basilea Receives GBP 146 Million (approximately CHF 225 Million) Upfront Payment". Basel. 2012-07-23
Novartis AG. (7/20/12). "Press Release: Novartis Gains FDA Approval for Afinitor in Advanced Breast Cancer Marking a Significant Milestone for Women Battling this Disease". Basel. 2012-07-20
Novartis AG. (7/19/12). "Press Release: Novartis Second Quarter Results Enhance Future Growth Prospects with Eight Significant Regulatory Milestones, on Track to Deliver 2012 Outlook". Basel. 2012-07-19
Roche. (7/19/12). "Press Release: FDA Clears Accu-Chek Combo System – Roche’s New Interactive Insulin Pump System for People with Diabetes. The System Will Be Available in the United States in the Second Half of 2012". Basel. 2012-07-19
Tecan Group Ltd.. (7/19/12). "Press Release: Powerful Walkaway qPCR Set-up from Tecan. The Roche LC480 Is Linked Directly to the Freedom EVO Workstation". Männedorf. 2012-07-19
Actelion Ltd.. (7/19/12). "Press Release: Actelion Announces Half Year 2012 Financial Results". Allschwil. 2012-07-19
Roche. (7/18/12). "Press Release: Roche Introduces Mobile Blood Gas Analyzer for Hospital Point-of-Care Testing in the United States. FDA Approval Grants Immediate Marketing of the cobas b 123 POC System in the U.S.". Rotkreuz. 2012-07-18
ADC Therapeutics S.a.r.l.. (7/17/12). "Press Release: ADC Therapeutics Appoints Former Genmab VP Dr Patrick van Berkel as Senior VP of R&D". Lausanne. 2012-07-17
Genedata AG. (7/16/12). "Press Release: Genedata Biologics Releases Advanced Support for High-throughput Protein Expression Workflows". Basel. 2012-07-16
Actelion Ltd.. (7/12/12). "Press Release: Actelion Announces Cost Saving Initiative to Be Implemented by the End of 2012. Initative Could Result in a Reduction of Up to 135 Positions". Allschwil. 2012-07-12
Genedata AG. (7/11/12). "Press Release: Takeda Selects Genedata Expressionist for Genomic Profiling". Tokyo. 2012-07-11
Lonza Group Ltd.. (7/10/12). "Press Release: Lonza Launches Next Generation GS Gene Expression System. The New GS Xceed Gene Expression System Provides Up to a 6 Week Reduction in Cell Line Construction". Basel. 2012-07-10
Genkyotex S.A.. (7/9/12). "Press Release: Genkyotex Closes CHF25 Million (USD26 Million) Extension to Its Series C Financing". Geneva & Archamps. 2012-07-09
Galenica Holding AG. (7/9/12). "Press Release: PA21 – Pivotal Phase III Study Met Primary and Secondary Endpoints. Preparations for Regulatory Filings Are Underway". 2012-07-09
Celtic Therapeutics Management L.L.L.P.. (7/6/12). "Press Release: Cancer Research Technology and ADC Therapeutics Join Forces on Antibody Drug Conjugates". London & Lausanne. 2012-07-06
Berthold Technologies GmbH & Co. KG. (7/5/12). "Press Release: Berthold Launches TriStar² Microplate Reader". Bad Wildbad. 2012-07-05
Roche. (7/5/12). "Press Release: Roche Complements Hemostasis Portfolio with the Multiplate Analyzer. Personalized Anti-platelet Therapy and Stratified Bleeding Risk with Unique Diagnostic Solution". Rotkreuz. 2012-07-05
Addex Therapeutics S.A.. (7/3/12). "Press Release: Addex Appoints Dr. Graham Dixon as Chief Scientific Officer and Head of Research". Geneva. 2012-07-03
Selexis S.A.. (6/27/12). "Press Release: Selexis Lubris Partnership Advances Difficult-to-Express Protein Towards Clinic. Lubris Achieves Over Gram per Liter of Recombinant Human Lubricin Using Selexis SUREtechnology Platform". Geneva. 2012-06-27
Biotie Therapies Corporation. (6/26/12). "Press Release: Biotie Announces Roche Has Decided to Not Exercise Its Rights to SYN120, a Novel 5-HT6 Antagonist for Cognitive Disorders". 2012-06-26
Roche. (6/26/12). "Press Release: Roche to Streamline Research and Development Activities. Roche Site in Nutley (New Jersey, USA) to Be Closed – Respective R&D Activities to Be Consolidated in Switzerland and Germany". Basel. 2012-06-26
CovalX AG. (6/26/12). "Press Release: The European Patent Office (EPO) Has Granted a European Patent to CovalX AG for a New Method to Charaterize the Effect of Potential Drugs on Protein-Protein Interactions". Zürich. 2012-06-26
Biocartis S.A.. (6/19/12). "Press Release: Immunexpress, Debiopharm, and Biocartis Announce Collaboration to Advance Development of SeptiCyte Triage for Managing Sepsis". Brisbane & Lausanne. 2012-06-19
Wilex AG. (6/14/12). "Press Release: Mesupron Met Its Primary Objective of Demonstrating Efficacy in the Proof of Concept Phase II Breast Cancer Trial". Munich. 2012-06-14
Basilea Pharmaceutica Ltd.. (6/11/12). "Press Release: Basilea Enters into Global Agreement with Stiefel, a GSK Company, for Toctino (alitretinoin). Stiefel Gains Exclusive Worldwide Rights to Toctino (altitretonin) and Assumes Toctino Distribution Agree 2012-06-11
Tecan Group Ltd.. (6/7/12). "Press Release: Tecan and Reinnervate Team Up for Automation of 3D Cell Culture. Reinnervate’s Alvetex Scaffold for 3D Cell Culture on Freedom EVO Liquid Handling Workstation". Männedorf. 2012-06-07
BioInvent International AB. (6/5/12). "Press Release: BioInvent and ThromboGenics to Regain Full Rights to TB-403. Plan to Evaluate the Potential of this Therapeutic Antibody against PlGF in Cancer and Non-cancer Indications, including Ophtalmology". Lun 2012-06-05
Addex Therapeutics S.A.. (6/5/12). "Press Release: Addex Partner to Initiate Phase 2 Clinical Trial of ADX71149 for the Treatment of Major Depressive Disorder with Anxiety Symptoms". Geneva. 2012-06-05
Lonza Group Ltd.. (6/1/12). "Press Release: Beat In-Albon New COO of the Life Science Ingredients Sector". Basel. 2012-06-01
CovalX AG. (6/1/12). "Press Release: The Institute of Molecular Systems Biology (IMSB, ETH) and CovalX Are Developing a New Methodology for Epitope Mapping". 2012-06-01
Basilea Pharmaceutica Ltd.. (5/25/12). "Press Release: Basilea Participates in Public-private Collaboration to Tackle Antibiotic Resistance". Basel. 2012-05-25
Selexis S.A.. (5/23/12). "Press Release: Selexis and Fusion Antibodies Services Form Partnership to Speed Therapeutic Monoclonal Antibody Development". Geneva. 2012-05-23
Lonza Group Ltd.. (5/16/12). "Press Release: Avalanche Biotechnologies, Inc. and Lonza Announce Global Manufacturing Collaboration for Adeno-associated Viral Vectors for Gene Therapy". San Francisco, CA & Houston, TX. 2012-05-16
Selexis S.A.. (5/15/12). "Press Release: Adienne Pharma & Biotech Signs Service Agreement with Selexis for the Development of a Novel Fully Human Mini-Antibody". Geneva. 2012-05-15
Merck KGaA. (5/15/12). "Press Release: Merck Announces Details of Merck Serono Efficiency Program and Introduces Merck Group Mid-term Financial Targets". Darmstadt. 2012-05-15
Biofrontera AG. (5/11/12). "Press Release: Biofrontera Publishes Interim Report for the 1st Quarter of 2012". Leverkusen. 2012-05-11
Evotec AG. (5/9/12). "Press Release: Evotec AG and 4-Antibody AG Form Strategic Collaboration to Innovate Antibody Selection. Evotec and 4-Antibody Launch New High Content Screening Platform for Early Antibody Functionality Testing". Hamburg & Basel. 2012-05-09
Addex Therapeutics S.A.. (5/9/12). "Press Release: Addex Shareholders Approve All Board Proposals at Annual General Meeting". Evanston, IL. 2012-05-09
Baliopharm AG. (5/9/12). "Press Release: Baliopharm Signs Licensing Agreement for the Development of a Bispecific Antibody Indicated for the Treatment of Cancer and Inflammatory Diseases". Basel & Tübingen. 2012-05-09
Sophia Genetics S.A.. (5/8/12). "Press Release: Sophia Genetics Raises CHF 840,000 Seed Funding with Private Investors". 2012-05-08
Intercell AG. (5/7/12). "Press Release: Intercell Announces EUR 25.0 Million Financing from BB Biotech and Proposed Private Placement with Selected Institutional [not for US, AU, CA, JP et al.]". Vienna. 2012-05-07
Addex Therapeutics S.A.. (5/4/12). "Press Release: Addex Completes Rightsizing of Its Operations. Cash Runway Extended to Fourth Quarter 2013". Geneva. 2012-05-04
Mondobiotech Holding AG. (5/3/12). "Press Release: Mondobiotech Holding AG (SIX: RARE) Announces the Results of Its Annual General Meeting and Re-elections in the Board of Directors". Stans. 2012-05-03
Mondobiotech Holding AG. (5/2/12). "Press Release: Mondobiotech Holding AG Announces Changes in the Composition of the Board of Directors". Stans. 2012-05-02
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23  next pagenext page


[iito] Business Intelligence – The Elephants Are Coming 560x91px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture [LSE] – The Business Web Portal 600x60px

» top